Literature DB >> 33469589

Mutation rates and selection on synonymous mutations in SARS-CoV-2.

Nicola De Maio1, Conor R Walker1, Yatish Turakhia2, Robert Lanfear3, Russell Corbett-Detig2, Nick Goldman1.   

Abstract

The COVID-19 pandemic has seen an unprecedented response from the sequencing community. Leveraging the sequence data from more than 140,000 SARS-CoV-2 genomes, we study mutation rates and selective pressures affecting the virus. Understanding the processes and effects of mutation and selection has profound implications for the study of viral evolution, for vaccine design, and for the tracking of viral spread. We highlight and address some common genome sequence analysis pitfalls that can lead to inaccurate inference of mutation rates and selection, such as ignoring skews in the genetic code, not accounting for recurrent mutations, and assuming evolutionary equilibrium. We find that two particular mutation rates, G→U and C→U, are similarly elevated and considerably higher than all other mutation rates, causing the majority of mutations in the SARS-CoV-2 genome, and are possibly the result of APOBEC and ROS activity. These mutations also tend to occur many times at the same genome positions along the global SARS-CoV-2 phylogeny (i.e., they are very homoplasic). We observe an effect of genomic context on mutation rates, but the effect of the context is overall limited. While previous studies have suggested selection acting to decrease U content at synonymous sites, we bring forward evidence suggesting the opposite.

Entities:  

Year:  2021        PMID: 33469589      PMCID: PMC7814826          DOI: 10.1101/2021.01.14.426705

Source DB:  PubMed          Journal:  bioRxiv


  42 in total

1.  PAML 4: phylogenetic analysis by maximum likelihood.

Authors:  Ziheng Yang
Journal:  Mol Biol Evol       Date:  2007-05-04       Impact factor: 16.240

2.  The genetic code is one in a million.

Authors:  S J Freeland; L D Hurst
Journal:  J Mol Evol       Date:  1998-09       Impact factor: 2.395

3.  Stability of SARS-CoV-2 phylogenies.

Authors:  Yatish Turakhia; Nicola De Maio; Bryan Thornlow; Landen Gozashti; Robert Lanfear; Conor R Walker; Angie S Hinrichs; Jason D Fernandes; Rui Borges; Greg Slodkowicz; Lukas Weilguny; David Haussler; Nick Goldman; Russell Corbett-Detig
Journal:  PLoS Genet       Date:  2020-11-18       Impact factor: 5.917

4.  A codon-based model of nucleotide substitution for protein-coding DNA sequences.

Authors:  N Goldman; Z Yang
Journal:  Mol Biol Evol       Date:  1994-09       Impact factor: 16.240

5.  MAFFT multiple sequence alignment software version 7: improvements in performance and usability.

Authors:  Kazutaka Katoh; Daron M Standley
Journal:  Mol Biol Evol       Date:  2013-01-16       Impact factor: 16.240

6.  A genome-wide map of hyper-edited RNA reveals numerous new sites.

Authors:  Hagit T Porath; Shai Carmi; Erez Y Levanon
Journal:  Nat Commun       Date:  2014-08-27       Impact factor: 14.919

7.  Rampant C→U Hypermutation in the Genomes of SARS-CoV-2 and Other Coronaviruses: Causes and Consequences for Their Short- and Long-Term Evolutionary Trajectories.

Authors:  P Simmonds
Journal:  mSphere       Date:  2020-06-24       Impact factor: 4.389

8.  IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era.

Authors:  Bui Quang Minh; Heiko A Schmidt; Olga Chernomor; Dominik Schrempf; Michael D Woodhams; Arndt von Haeseler; Robert Lanfear
Journal:  Mol Biol Evol       Date:  2020-05-01       Impact factor: 16.240

9.  No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2.

Authors:  Lucy van Dorp; Damien Richard; Cedric C S Tan; Liam P Shaw; Mislav Acman; François Balloux
Journal:  Nat Commun       Date:  2020-11-25       Impact factor: 14.919

10.  Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.

Authors:  Bette Korber; Will M Fischer; Sandrasegaram Gnanakaran; Hyejin Yoon; James Theiler; Werner Abfalterer; Nick Hengartner; Elena E Giorgi; Tanmoy Bhattacharya; Brian Foley; Kathryn M Hastie; Matthew D Parker; David G Partridge; Cariad M Evans; Timothy M Freeman; Thushan I de Silva; Charlene McDanal; Lautaro G Perez; Haili Tang; Alex Moon-Walker; Sean P Whelan; Celia C LaBranche; Erica O Saphire; David C Montefiori
Journal:  Cell       Date:  2020-07-03       Impact factor: 66.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.